JP2023524970A5 - - Google Patents

Info

Publication number
JP2023524970A5
JP2023524970A5 JP2022567249A JP2022567249A JP2023524970A5 JP 2023524970 A5 JP2023524970 A5 JP 2023524970A5 JP 2022567249 A JP2022567249 A JP 2022567249A JP 2022567249 A JP2022567249 A JP 2022567249A JP 2023524970 A5 JP2023524970 A5 JP 2023524970A5
Authority
JP
Japan
Prior art keywords
approximately
substituted
deuterium
halogen
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2022567249A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023524970A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/030363 external-priority patent/WO2021225912A1/en
Publication of JP2023524970A publication Critical patent/JP2023524970A/ja
Publication of JP2023524970A5 publication Critical patent/JP2023524970A5/ja
Withdrawn legal-status Critical Current

Links

JP2022567249A 2020-05-07 2021-04-30 アミノ酸化合物による呼吸器疾患の治療 Withdrawn JP2023524970A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063021674P 2020-05-07 2020-05-07
US63/021,674 2020-05-07
PCT/US2021/030363 WO2021225912A1 (en) 2020-05-07 2021-04-30 Treatment of respiratory diseases with amino acid compounds

Publications (2)

Publication Number Publication Date
JP2023524970A JP2023524970A (ja) 2023-06-14
JP2023524970A5 true JP2023524970A5 (https=) 2024-04-30

Family

ID=78468277

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022567249A Withdrawn JP2023524970A (ja) 2020-05-07 2021-04-30 アミノ酸化合物による呼吸器疾患の治療

Country Status (10)

Country Link
US (1) US20230181546A1 (https=)
EP (2) EP4520329A3 (https=)
JP (1) JP2023524970A (https=)
KR (1) KR20230049584A (https=)
CN (1) CN115989235A (https=)
AU (1) AU2021268889A1 (https=)
CA (1) CA3173761A1 (https=)
IL (1) IL297969A (https=)
MX (1) MX2022013753A (https=)
WO (1) WO2021225912A1 (https=)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3509590A4 (en) 2016-09-07 2020-12-02 Pliant Therapeutics, Inc. N-ACYL AMINO ACID COMPOUNDS AND METHODS OF USE
US10696672B2 (en) 2016-12-23 2020-06-30 Pliant Therapeutics, Inc. Amino acid compounds and methods of use
FI3761980T3 (fi) 2018-03-07 2024-02-21 Pliant Therapeutics Inc Aminohappoyhdisteitä ja käyttömenetelmiä
TWI841573B (zh) 2018-06-27 2024-05-11 美商普萊恩醫療公司 具有未分支連接子之胺基酸化合物及使用方法
TW202028179A (zh) 2018-10-08 2020-08-01 美商普萊恩醫療公司 胺基酸化合物及使用方法
CN114173803A (zh) 2019-04-08 2022-03-11 普利安特治疗公司 氨基酸化合物的剂型和方案
EP4247472A4 (en) * 2020-11-19 2024-10-09 Pliant Therapeutics, Inc. INTEGRIN INHIBITORS AND USES THEREOF
MX2023012794A (es) * 2021-04-30 2023-12-15 Pliant Therapeutics Inc Regímenes de dosificación expandidos para inhibidores de integrina.
CN120091811A (zh) * 2022-07-09 2025-06-03 普利安特治疗公司 整合素抑制剂及其与其它药剂组合的用途
EP4626878A1 (en) 2022-12-02 2025-10-08 Neumora Therapeutics, Inc. Methods of treating neurological disorders
WO2024125634A1 (zh) * 2022-12-16 2024-06-20 西藏海思科制药有限公司 一种四氢萘啶类化合物及其在医药上的应用
WO2024235299A1 (zh) * 2023-05-17 2024-11-21 西藏海思科制药有限公司 一种羧基衍生物及其在医药上的应用
WO2025067384A1 (zh) * 2023-09-28 2025-04-03 成都微芯药业有限公司 一类氨基酸整联蛋白抑制剂、其制备方法及其应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE511850T1 (de) * 1997-08-08 2011-06-15 Univ California Behandlung von blasenfibrose mit antikörpern gegen alpha-v-beta-6-integrin
DE10204789A1 (de) * 2002-02-06 2003-08-14 Merck Patent Gmbh Inhibitoren des Integrins alpha¶v¶beta6
US9790222B2 (en) * 2015-02-19 2017-10-17 Scifluor Life Sciences, Inc. Fluorinated tetrahydronaphthyridinyl nonanoic acid derivatives and uses thereof
BR112017023432A2 (pt) * 2015-04-30 2018-07-24 Scifluor Life Sciences Inc Derivados de ácido propiônico tetra- hidronaftiridinila e usos do mesmo
US10118929B2 (en) * 2016-04-27 2018-11-06 Scifluor Life Sciences, Inc. Nonanoic and decanoic acid derivatives and uses thereof
WO2018183795A1 (en) * 2017-03-30 2018-10-04 Scifluor Life Sciences, Inc. Method of making tetrahydronaphthyridinyl nonanoic acid compounds
FI3761980T3 (fi) * 2018-03-07 2024-02-21 Pliant Therapeutics Inc Aminohappoyhdisteitä ja käyttömenetelmiä
BR112021006622A2 (pt) * 2018-10-09 2021-07-20 Medimmune, Llc combinações de anticorpos anti-staphylococcus aureus

Similar Documents

Publication Publication Date Title
JP2023524970A5 (https=)
JP6924744B2 (ja) B型肝炎ウイルスに対する組成物および薬剤ならびにその使用
JP5389668B2 (ja) 皮膚浸透率の非常に高い1H−イミダゾ[4,5−c]キノリン−4−アミン及び関連化合物の正に荷電した水溶性プロドラッグ
JP2022116170A5 (https=)
KR100270806B1 (ko) 5-플루오로-2`-데옥시-3`-티아시티딘을 함유하는 b형 간염 치료를 위한 약제
ES2559687T3 (es) Composición y métodos para modular una cascada de cinasa
ES2250200T3 (es) Derivados de naftiridina.
JP2007516983A5 (https=)
JP2017531038A5 (https=)
JP2017537949A5 (https=)
JP2012236838A5 (https=)
JP2019529484A5 (https=)
BR112021007362A2 (pt) inibidores da replicação do vírus da imunodeficiência humana
JP2018535967A5 (https=)
SK285231B6 (sk) Použitie 6-[(imidazol-5-yl)metyl]chinolínovej zlúčeniny na prípravu farmaceutickej kompozície na liečbu artropatie
JP2008513498A5 (https=)
JP2017514838A5 (https=)
JP2012530703A5 (https=)
JP2012041365A5 (https=)
JP2023520925A5 (https=)
JP5654467B2 (ja) 4−アミノ−3−(イミダゾリル)−ピラゾロ[3,4−d]ピリミジン
JP2009507909A5 (https=)
EA037372B1 (ru) Ингибиторы репликации вирусов гриппа
JP2019505529A5 (https=)
JP2013518036A5 (https=)